Founded by an EP cardiologist/engineer with a passion for innovation. YC S21.
SafeBeat Rx: the first ECG AI to go beyond diagnostics and recommend treatment
So incredibly proud of our @SafeBeat team for launching the first ECG AI tool to recommend treatment. Important collaborations with @UCSFCardiology, @MassGenBrigham, now @CVAUSA1 on the importance of long-term QTc monitoring @TheCardioFL
Hard to pick a favorite #HRS2026 moment 🫀
Unexpected #HRS2026 win: making @DGlaucomflecken laugh
Thanks for sharing your moving experience as an SCA survivor and reminding us of the impact on your wife @LGlaucomflecken post arrest.
Pls do an EP character, we need some screen time as the scarcest US specialty🙏 @HRSonline
Stepped onto a different kind of stage to kickoff #HRS2026 🎤 “Make You Feel My Love” at the President’s Welcome Reception, dedicated to Baby Rian. Thanks #Dysrhythmics for keeping my tradition alive as singer of my med school band #ThePacemakers
Excited for #HRS2026! 🔬✨
We’re presenting 3 research studies highlighting our work as the first ECG-based AI tool that helps guide treatment decisions.
Proud to push innovation forward in cardiac care. 💡
#Cardiology#EPeeps#HeartRhythm@HRSonline
Tonight at 7 EST🚨
Don’t miss the #ACC26 EP highlights, presented by @ACCintouch EP leadership council. Hear from experts on AFib care, wearables, and key studies like CHAMPION-AF. Honored our @SafeBeat research will be highlighted in the EP AI segment.
#Cardiology#AFib#EP
Energizing #ACC26: 4 @SafeBeat presentations, co-chairing AI in EP session we proposed with this ⭐️ cast, and official FACC hooding - full circle moment from high school anatomy, lying awake excited by my own heart pumping. Excited to keep advancing #AFib care @ACCinTouch
Big news! @DrRachitaEP is heading to #ACC26 in New Orleans, March 28–30. 🩺 She is a featured panel co-chair and will be presenting 4 of our research abstracts on QTc dynamics, drug safety, and EMR automation. @ACCinTouch
Come learn about the future of EP AI! #EP#EPpeeps
That’s a wrap on #AFSymposium2026! Grateful to present 2 abstracts exploring QTc dynamics and real-world antiarrhythmic experiences in clinical practice. Thankful for the meaningful discussions and collaboration. Excited to keep advancing #AFib care together. 🫀
We’re excited to share that the @SafeBeat team will be presenting 2 abstracts at #AFSymposium2026, Feb 5–7 at the Omni Boston at the Seaport. Our work explores QTc dynamics and antiarrhythmic drug titration. Looking forward to connecting in Boston! 🫀
#HRX2025 was a blast! Thrilled to share how @SafeBeat is bringing AI to real clinical workflows, from QTc to AF drug dosing. Huge thanks to @HRSonline@experienceHRX and the #EPeeps for keeping the digital heart health revolution alive.
Our HRS white paper on persistent AF care is out on the 3y HRX anniversary of our first #EmergingLeaders. Thanks to persistent teamwork (pun intended). Proud to work w/ @HeartRhythmSociety to advance digital health, wearables, & continuous monitoring. https://t.co/AyrjY6yeNk
Can’t wait to connect with innovative minds at #HRX2025! I’ll be sharing how our software goes beyond diagnostics to power AFib treatment, including long-term monitoring and patient engagement. Come join me. See you in Atlanta! @experienceHRX
It was pretty epic meeting Dr. @EricTopol and talking longevity and telling him about the work we're doing @SafeBeat . His book, Super Agers, has a whole chapter on Atrial Fibrillation, which is an age related disease. One in three Americans are expected to deal with Atrial Fibrillation. Lifestyle/longevity approaches and antiarrhythmics help treat it and prevent recurrence and significantly reduce the risk of stroke and mortality (~by 17%, amount to about 200,000 lives saved in the US each year). Stay tuned for more updates!
Great #longevity talk by @EricTopol for @ycombinator on the importance of rigorous human studies & the promise of AI to extend healthspan through data-driven, personalized interventions.
Thanks for your latest book, and excited to keep building the future of cardiology @SafeBeat
Thrilled that @SafeBeat was selected as a @MedTechAwards showcase company at @DeviceTalks Boston! We unveiled our tailored cardiac monitoring platform and shared milestones like completing preclinical validation and launching our first clinical pilots. #MedTechInnovator
So proud of our @SafeBeat research team #HRS2025 presentations🫀❤️🔥 One of our studies demonstrates that our explainable AI antiarrhythmic dosing platform allows EPs to rapidly approve ECGs (1.1 min) and AAD dosing decisions (2.9 min) in real-time. #Afib#EPeeps@HRSonline